This site is intended for health professionals only

Home
>
Respiratory

Respiratory

Rethinking the fight against TB: insights from ESCMID Global

Bridging the access gap for biosimilars in severe asthma

Bridging the access gap for biosimilars in severe asthma

AMS programme improves optimal antibiotic use for pneumonia in children

AMS programme improves optimal antibiotic use for pneumonia in children

Dupilumab found to improve quality of life and reduce treatment-related anxiety in children

Dupilumab found to improve quality of life and reduce treatment-related anxiety in children

Low-carbon COPD triple combination inhaler gains world-first approval

Low-carbon COPD triple combination inhaler gains world-first approval

Nirmatrelvir plus ritonavir withdrawn by NICE for some at-risk groups

Nirmatrelvir plus ritonavir withdrawn by NICE for some at-risk groups

Real-world impact of medication adherence in pulmonary hypertension identified

Real-world impact of medication adherence in pulmonary hypertension identified

Final chance to explore the agenda and register for Clinical Excellence in Respiratory Care

Final chance to explore the agenda and register for Clinical Excellence in Respiratory Care

Optimum timing for beclomethasone inhaler use identified by researchers

Optimum timing for beclomethasone inhaler use identified by researchers

A pharmacist’s take on actions from the child asthma and anaphylaxis deaths report

A pharmacist’s take on actions from the child asthma and anaphylaxis deaths report

Lazertinib gains MHRA approval for NSCLC due to superior benefit over standard of care

Lazertinib gains MHRA approval for NSCLC due to superior benefit over standard of care

Clinical Excellence in Respiratory Care: May 2025

Clinical Excellence in Respiratory Care: May 2025

1 2 3 … 64 Next »

Be in the know

Subscribe to Hospital Pharmacy Europe newsletter and magazine

Subscribe

x